Lisa Salberg and Dr. Martin Maron take a fresh look at the long-standing role of beta blockers in HCM and how newer myosin inhibitors are changing the treatment conversation. They also discuss upcoming clinical data, fibrosis, symptom changes, and how patients can better navigate evolving care.

This conversation was recorded Aug. 14, 2026